Symbol
KPTI on Nasdaq
Investment type
Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Ownership
1.57M shares
Security Ownership
9.48%

Opaleye Management Inc. ownership in Karyopharm Therapeutics Inc. Common Stock, par value $0.0001 per share (KPTI)

2025-10-17 - Opaleye Management Inc. has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 1.57M shares of Karyopharm Therapeutics Inc. Common Stock, par value $0.0001 per share (KPTI). This represents 9.48% percent ownership of the company.